Arkolith/Insider Trading/APVO/Form 4

Lamothe Jeffrey G.

EVP, COOAptevo Therapeutics Inc. (APVO) · full profile →Form 4 · filed Mar 4, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2025Option exercise(M)2——36
Mar 2, 2025Option exercise(M)3——34

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2025Option exercise(M)2—$00
Mar 2, 2025Option exercise(M)3—$04

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-032197) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML